EPCAM and adenocarcinoma: In summary, our data provide a comprehensive overview on EpCAM expression in cancer and confirm the suitability of EpCAM as a surrogate epithelial marker for adenocarcinomas and its diagnostic utility for the distinction of malignant mesotheliomas from pulmonary adenocarcinoma.